

Health Care: Drugs
GlaxoSmithKline PLC (GSK: NYSE)
$52.25 -0.22 | -0.42%
06/19/13 - 10:05 AM ET
Partner Headlines for GSK
- Dynavax Down on Heplisav Delay - Analyst Blog - Zacks 06.12.13 | 12:06 am
- Parexel Trying To Clear Three-Weeks-Tight Buy Point - Investor's Business Daily 06.11.13 | 06:06 pm
- FDA Panel Positive on GSK's Avandia - Analyst Blog - Zacks 06.07.13 | 10:06 pm
- Impax Reduces Workforce - Analyst Blog - Zacks 06.07.13 | 01:06 am
- What Must Be In The Ideal Biopharmaceutical Portfolio? - Seeking Alpha 06.05.13 | 09:06 am
- GSK/Genmab Report Positive Arzerra Data - Analyst Blog - Zacks 05.31.13 | 11:05 pm
- Stocks Market News for May 30, 2013 - Market News - Zacks 05.30.13 | 03:05 pm
- After Hours Most Active for May 29, 2013 : SIRI, GE, SPF, CSCO, SYMC, VOD, NLY, NRF, BAC, GSK, MSFT, STEI - NASDAQ 05.29.13 | 08:05 pm
- UPDATE: Deutsche Bank Upgrades GlaxoSmithKline to a Buy on Risk/Reward Move to Positive - Benzinga 05.28.13 | 09:05 am
- Elan Rejects Royalty Offer Again - Analyst Blog - Zacks 05.24.13 | 10:05 pm